For the quarter ending 2025-09-30, PLRX has $276,600K in assets. $76,294K in debts. $93,732K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 93,732 | 86,820 | ||
| Short-term investments | 148,065 | 176,053 | ||
| Prepaid expenses and other current assets (note 5) | 3,791 | 4,571 | ||
| Total current assets | 245,588 | 267,444 | ||
| Property and equipment, net (note 4) | 4,344 | 4,892 | ||
| Operating lease right-of-use assets (note 15) | 24,794 | 25,615 | ||
| Restricted cash | 1,482 | 1,482 | ||
| Other non-current assets | 392 | 391 | ||
| Total assets | 276,600 | 299,824 | ||
| Accounts payable | 485 | 1,384 | ||
| Accrued research and development | 7,779 | 10,790 | ||
| Accrued liabilities (note 6) | 8,173 | 7,192 | ||
| Operating lease liabilities, current (note 15) | 1,187 | 1,225 | ||
| Total current liabilities | 17,624 | 20,591 | ||
| Operating lease liabilities, non-current (note 15) | 28,231 | 28,791 | ||
| Long-term debt (note 7) | 30,439 | 30,360 | ||
| Total liabilities | 76,294 | 79,742 | ||
| Common stock, 0.0001 par value per share 300,000,000 shares authorized at september 30, 2025 and december 31, 2024 and 61,449,290 and 60,860,838 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively (note 9) | 6 | 6 | ||
| Additional paid-in capital | 1,036,085 | 1,029,595 | ||
| Accumulated deficit | -835,819 | -809,518 | ||
| Accumulated other comprehensive gain | 34 | -1 | ||
| Total stockholders equity | 200,306 | 220,082 | ||
| Total liabilities and stockholders equity | 276,600 | 299,824 | ||
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)